bullish

Mayne Pharma

Mayne Pharma (MYX AU): Cosette's A$7.40/Share Scheme

377 Views21 Feb 2025 01:43
Clean deal. Trading tightish at 2.7%/10% gross/annualised spread, assuming early June completion. If in, stay in.  If small, illiquid arbs are your bent, look to enter here and on any weakness.
What is covered in the Full Insight:
  • Introduction to Scheme Implementation Deed
  • Details of Cosette Pharmaceuticals' Offer
  • Shareholder and Regulatory Support
  • Market Implications and Trading Strategy
  • Fundamentals and Share Performance of Mayne Pharma
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 3-minute read)
Discussions
(Paid Plans Only)
chart-bar
Logo
Top 5%
David Blennerhassett
Pan-Asia Catalysts/Events
Quiddity Advisors
EquitiesEvent-Driven
Price Chart(Sign Up to Access)
analytics-chart
  • Mayne Pharma (MYX AU): Cosette's A$7.40/Share Scheme
    21 Feb 2025
x